108 related articles for article (PubMed ID: 27444222)
1. Deal watch: Merck bets on purine receptor revival.
Cully M
Nat Rev Drug Discov; 2016 Aug; 15(8):525. PubMed ID: 27444222
[No Abstract] [Full Text] [Related]
2. Purinergic receptors.
Malec D
Pol J Pharmacol; 1996; 48(5):457-65. PubMed ID: 9112687
[TBL] [Abstract][Full Text] [Related]
3. Deal watch: Merck invests in pioneering cytomegalovirus programme.
Crunkhorn S
Nat Rev Drug Discov; 2012 Dec; 11(12):896. PubMed ID: 23197025
[No Abstract] [Full Text] [Related]
4. Deal watch: Genentech dives deeper into the next wave of cancer immunotherapies.
Crunkhorn S
Nat Rev Drug Discov; 2014 Dec; 13(12):879. PubMed ID: 25435209
[No Abstract] [Full Text] [Related]
5. Trial watch: Trends in clinical trial design complexity.
Getz KA; Campo RA
Nat Rev Drug Discov; 2017 May; 16(5):307. PubMed ID: 28417986
[No Abstract] [Full Text] [Related]
6. Deal watch: recent trends in deal-making.
Dawkes A; Papp T
Nat Rev Drug Discov; 2010 Dec; 9(12):909. PubMed ID: 21119724
[No Abstract] [Full Text] [Related]
7. Market watch: Upcoming catalysts in Q3 2014.
Haggerty R
Nat Rev Drug Discov; 2014 Jul; 13(7):486. PubMed ID: 24981351
[No Abstract] [Full Text] [Related]
8. Market watch: upcoming market catalysts in Q3 2012.
Jeng R
Nat Rev Drug Discov; 2012 Jun; 11(7):508. PubMed ID: 22743969
[No Abstract] [Full Text] [Related]
9. Market watch: Upcoming market catalysts in Q4 2013.
Fong S
Nat Rev Drug Discov; 2013 Oct; 12(10):731. PubMed ID: 24080689
[No Abstract] [Full Text] [Related]
10. Market watch: Upcoming market catalysts in Q3 2013.
Roybal D
Nat Rev Drug Discov; 2013 Jul; 12(7):496. PubMed ID: 23812261
[No Abstract] [Full Text] [Related]
11. Market watch: upcoming market catalysts in Q1 2013.
Inui E
Nat Rev Drug Discov; 2013 Jan; 12(1):12. PubMed ID: 23274459
[No Abstract] [Full Text] [Related]
12. Market watch: upcoming market catalysts in Q2 2011.
Jeng R
Nat Rev Drug Discov; 2011 Apr; 10(4):248. PubMed ID: 21455226
[No Abstract] [Full Text] [Related]
13. Market watch: upcoming market catalysts in Q1 of 2010.
Rosenthal J
Nat Rev Drug Discov; 2010 Jan; 9(1):11. PubMed ID: 20043022
[No Abstract] [Full Text] [Related]
14. Market watch: Upcoming market catalysts in Q3 2016.
Ranj T
Nat Rev Drug Discov; 2016 Jul; 15(7):449. PubMed ID: 27282354
[No Abstract] [Full Text] [Related]
15. Deal watch: AbbVie invests in pioneering celiac disease therapy.
Crunkhorn S
Nat Rev Drug Discov; 2013 Jul; 12(7):497. PubMed ID: 23812262
[No Abstract] [Full Text] [Related]
16. Deal watch: Amgen builds secondary hyperparathyroidism [corrected] pipeline.
Tse MT
Nat Rev Drug Discov; 2012 Jun; 11(6):430. PubMed ID: 22653204
[No Abstract] [Full Text] [Related]
17. Deal watch: Biopharma deal-making in 2015: changing the pharma landscape.
Micklus A; Muntner S
Nat Rev Drug Discov; 2016 Feb; 15(2):78-9. PubMed ID: 26837586
[No Abstract] [Full Text] [Related]
18. Market watch: Therapeutic area 'heat map' for emerging markets.
Gautam A; Li L; Srinivasan K
Nat Rev Drug Discov; 2015 Aug; 14(8):518-9. PubMed ID: 26160486
[No Abstract] [Full Text] [Related]
19. An electrophysiological study of excitatory purinergic neuromuscular transmission in longitudinal smooth muscle of chicken anterior mesenteric artery.
Khalifa M; El-Mahmoudy A; Shiina T; Shimizu Y; Nikami H; El-Sayed M; Kobayashi H; Takewaki T
Br J Pharmacol; 2005 Mar; 144(6):830-9. PubMed ID: 15685211
[TBL] [Abstract][Full Text] [Related]
20. Deal watch: Celgene bets big on Scripps-originated autoimmunity candidate.
Cully M
Nat Rev Drug Discov; 2015 Sep; 14(9):595. PubMed ID: 26294266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
